Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

Liberatore, Gabriel T., Jackson-Lewis, Vernice, Vukosavic, Slobodanka, Mandir, Allen S., Vila, Miquel, McAuliffe, W. Geoffrey, Dawson, Valina L., Dawson, Ted M. +1 more·1999·Nature Medicine

DOI 10.1038/70978

Cited by (1,000)

Items 701–800 of 1,000

Counteracting neuroinflammation in experimental Parkinson’s disease favors recovery of function: effects of Er-NPCs administration
Stephana Carelli, Toniella Giallongo, Zuzana Tonelli Gombalová, Federica Rey, Maria Carlotta Gorio, Massimiliano Mazza, Anna Maria Di Giulio · 2018 · Journal of Neuroinflammation
Oxidation of DOPAC by nitric oxide: effect of superoxide dismutase
João A.N. Laranjinha, Enrique Cadenas · 2002 · Journal of Neurochemistry
Antagonistic pleiotropic effects of nitric oxide in the pathophysiology of Parkinson's disease
Deepanjali Tripathy, J. Chakraborty, Kochupurackal P. Mohanakumar · 2015 · Free Radical Research
Brain Damage - Bridging Between Basic Research and Clinics
Alina González-Quevedo · 2012 · InTech eBooks
SUN11602, a bFGF mimetic, modulated neuroinflammation, apoptosis and calcium-binding proteins in an in vivo model of MPTP-induced nigrostriatal degeneration
Alessio Ardizzone, Valentina Bova, Giovanna Casili, Alessia Filippone, Michela Campolo, Marika Lanza, Emanuela Esposito, Irene Paterniti · 2022 · Journal of Neuroinflammation
Comparative pharmacological study of free radical scavenger, nitric oxide synthase inhibitor, nitric oxide synthase activator and cyclooxygenase inhibitor against MPTP neurotoxicity in mice
Hironori Yokoyama, Ryohei Yano, Eriko Aoki, Hiroyuki Kato, Tsutomu Araki · 2008 · Metabolic Brain Disease
Proteomics as a new paradigm to tackle Parkinson’s disease research challenges
Virginie Licker, Pierre R. Burkhard · 2014 · Translational Proteomics
Acorus gramineus inhibits microglia mediated neuroinflammation and prevents neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease
Jun Jiang, Jae‐Jin Kim, Dong‐Young Kim, Myong-Ki Kim, Nahyun Oh, Sushruta Koppula, Pyo‐Jam Park, Dong‐Kug Choi, Yong-Kook Shin, Ickhee Kim et al. · 2012 · Journal of Ethnopharmacology
Protective effects of synthetic kynurenines on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
Darı́o Acuña-Castroviejo, Vı́ctor Tapias, Luis Carlos López, Carolina Doerrier, Encarnación Camacho, María Dora Carriòn, Francisco Mora, Antonio Espinosa, Germaine Escames · 2011 · Brain Research Bulletin
Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine)-induced mouse model of Parkinson’s disease
Hironori Yokoyama, Hayato Kuroiwa, Jiro Kasahara, Tsutomu Araki · 2011 · Acta Neurobiologiae Experimentalis
Edible bird’s nest improves motor behavior and protects dopaminergic neuron against oxidative and nitrosative stress in Parkinson’s disease mouse model
Mei Yeng Yew, Rhun Yian Koh, Soi Moi Chye, Iekhsan Othman, Tomoko Soga, Ishwar S. Parhar, Khuen Yen Ng · 2018 · Journal of Functional Foods
Combination of Human Mesenchymal Stem Cells and Repetitive Transcranial Magnetic Stimulation Enhances Neurological Recovery of 6-Hydroxydopamine Model of Parkinsonian’s Disease
Ji Yong Lee, Hyun Soo Kim, Sung Hoon Kim, Han-Soo Kim, Byung Pil Cho · 2020 · Tissue Engineering and Regenerative Medicine
Literature-related discovery: common factors for Parkinson’s Disease and Crohn’s Disease
Ronald Neil Kostoff · 2014 · Scientometrics
The aqueous extract from Toona sinensis leaves inhibits microglia‐mediated neuroinflammation
Chao‐Chuan Wang, Yee-Jean Tsai, Ya‐Ching Hsieh, Rong‐Jyh Lin, Chih‐Lung Lin · 2013 · The Kaohsiung Journal of Medical Sciences
Activated microglia: The silent executioner in neurodegenerative disease?
Stanley H. Appel, Ericka P. Simpson · 2001 · Current Neurology and Neuroscience Reports
Age-related alteration of activity and gene expression of endothelial nitric oxide synthase in different parts of the brain in rats
Joanna Benigna Strosznajder, Henryk M. Jęśko, Agata Zambrzycka, Anne Eckert, Małgorzata Chalimoniuk · 2004 · Neuroscience Letters
Pathways of dopamine oxidation mediated by nitric oxide
Daniel Rettori, Yue Tang, Lauro Camargo Dias, Enrique Cadenas · 2002 · Free Radical Biology and Medicine
Investigation of anti-Parkinson activity of dicyclomine
Maham Sanawar, Uzma Saleem, Fareeha Anwar, Samra Nazir, Muhammad Furqan Akhtar, Bashir Ahmad, Tariq Ismail · 2020 · International Journal of Neuroscience
Post treatment with Gastrodin suppresses oxidative stress and attenuates motor disorders following 6-OHDA induced Parkinson disease
Zohre Sadeghian, Shahla Eyvari Brooshghalan, Mohammadmahdi Sabahi, Nahal Nourouzi, Rasool Haddadi · 2022 · Neuroscience Letters
Nitric Oxide a new player in L-DOPA-induced dyskinesia
Elaine Del-Bel · 2015 · Frontiers in Bioscience-Elite
Parkinson’s disease: what the model systems have taught us so far
Swagata Ghatak, Dorit Trudler, Nima Dolatabadi, Rajesh Ambasudhan · 2018 · Journal of Genetics
Ghrelin mitigates MPP+-induced cytotoxicity: Involvement of ERK1/2-mediated Nrf2/HO-1 and endoplasmic reticulum stress PERK signaling pathway
Huiqing Wang, Shanshan Dou, Junge Zhu, Ziqi Shao, Chunmei Wang, Baohua Cheng · 2020 · Peptides
Thrombin-induced microglial activation contributes to the degeneration of nigral dopaminergic neurons in vivo
Cheng-Fang Huang, Gang Li, Rong Ma, Shenggang Sun, Jianguo Chen · 2008 · Neuroscience Bulletin
Neuroprotective Effects of Cuscutae Semen in a Mouse Model of Parkinson’s Disease
Minsook Ye, Seul Gi Lee, Eun Sook Chung, Su-Jin Lim, Won Seob Kim, Heera Yoon, Sun Kwang Kim, Kwang Sung Ahn, Young Pyo Jang, Hyunsu Bae · 2014 · Evidence-based Complementary and Alternative Medicine
Zinc protoporphyrin inhibition of lipopolysaccharide-, lipoteichoic acid-, and peptidoglycan-induced nitric oxide production through stimulating iNOS protein ubiquitination
Jyh‐Ming Chow, Hui-Yi Lin, Shing‐Chuan Shen, Ming‐Shun Wu, Cheng‐Wei Lin, Wen‐Ta Chiu, Chien‐Huang Lin, Yen‐Chou Chen · 2009 · Toxicology and Applied Pharmacology
N , N ′-Disubstituted thiourea and urea derivatives: design, synthesis, docking studies and biological evaluation against nitric oxide synthase
Mariem Chayah, María Encarnación Camacho, María Dora Carriòn, Miguel Á. Gallo, Miguel Romero, Juan Duarte · 2016 · MedChemComm
Interleukin-1 Beta and Tumor Necrosis Factor Alpha Upregulation and Nuclear Factor Kappa B Activation in Skeletal Muscle from a Mouse Model of Chronic/Progressive Parkinson Disease
Nour S. Erekat, Muhammed D. Al-Jarrah · 2018 · Medical Science Monitor
Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity
Toshiki Himeda, Naoto Kadoguchi, Yuko Kamiyama, Hiroyuki Kato, Hitoshi Maegawa, Tsutomu Araki · 2005 · Neuropharmacology
Designing neuroprotection trials in Parkinson's disease
Karl D. Kieburtz · 2003 · Annals of Neurology
Glia‐conditioned medium induces de novo synthesis of tyrosine hydroxylase and increases dopamine cell survival by differential signaling pathways
Sonsoles de Bernardo, Santiago Canals, Marı́a José Casarejos, Eulalia Rodríguez‐Martín, M. A. Mena · 2003 · Journal of Neuroscience Research
Reply: a new look at the pathogenesis of Parkinson’s disease
Serge Przedborski, Miquel Vila, Vernice R. Jackson-Lewis, Ted M. Dawson · 2000 · Trends in Pharmacological Sciences
S-Nitrosylation of G protein-coupled receptor kinase 6 and Casein kinase 2 alpha modulates their kinase activity toward alpha-synuclein phosphorylation in an animal model of Parkinson’s disease
Weiwei Wu, Chun Chau Sung, Peichun Yu, Jiahua Li, Kenny K. K. Chung · 2020 · PLoS ONE
Disease-Toxicant Interactions in Parkinson’s Disease Neuropathology
Gunnar F. Kwakye, Rachael A. McMinimy, Michael Aschner · 2016 · Neurochemical Research
Brain structural changes in cynomolgus monkeys administered with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A longitudinal voxel-based morphometry and diffusion tensor imaging study
Hyeonseok S. Jeong, Sang‐Rae Lee, Jieun E. Kim, In Kyoon Lyoo, Sujung J. Yoon, Eun Namgung, Kyu-Tae Chang, Bom Sahn Kim, Sejung Yang, Jooyeon Jamie Im et al. · 2018 · PLoS ONE
The Peculiar Facets of Nitric Oxide as a Cellular Messenger: From Disease-Associated Signaling to the Regulation of Brain Bioenergetics and Neurovascular Coupling
João A.N. Laranjinha, Carla Nunes, Ana Ledo, Cátia F. Lourenço, Bárbara S. Rocha, Rui M. Barbosa · 2020 · Neurochemical Research
DAP12 and CD11b contribute to the microglial-induced death of dopaminergic neurons in vitro but not in vivo in the MPTP mouse model of Parkinson’s disease
Kiyoka Kinugawa, Yann Monnet, Catherine Béchade, Daniel Alvarez‐Fischer, Étienne C. Hirsch, Alain Bessis, Stéphane Hunot · 2013 · Journal of Neuroinflammation
Pycnogenol Protects Against Rotenone-Induced Neurotoxicity in PC12 Cells Through Regulating NF-κB-iNOS Signaling Pathway
Bo Gao, Chongwang Chang, Jie Zhou, Tianzhi Zhao, Chao Wang, Chen Li, Guodong Gao · 2015 · DNA and Cell Biology
Altered expression of Mg2+ transport proteins during Parkinson's disease-like dopaminergic cell degeneration in PC12 cells
Yutaka Shindo, Ryu Yamanaka, Koji A. O. Suzuki, Kohji Hotta, Kotaro Oka · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Towards New Therapies for Parkinson's Disease
David Isaac Finkelstein · 2011 · InTech eBooks
Midbrain neuronal cultures from parkin mutant mice are resistant to nitric oxide-induced toxicity
Rosa Maria Solano, J. Menéndez, Marı́a José Casarejos, José Antonio Rodríguez‐Navarro, Justo Garcı́a de Yébenes, M. A. Mena · 2006 · Neuropharmacology
Survival and differentiation of transplanted neural stem cells in mice brain with MPTP-induced Parkinson disease.
Xuekun Li, Anchen Guo, Pingping Zuo · 2003 · PubMed
Engineered modeling and the secrets of Parkinson's disease
Miquel Vila, Du Chu Wu, Serge Przedborski · 2001 · Trends in Neurosciences
Literature-Related Discovery (LRD)
Ronald Neil Kostoff, Joel A. Block, Jeffrey L. Solka, Michael Brandon Briggs, Robert L. Rushenberg, Jesse A. Stump, Dustin Johnson, Terence J. Lyons, Jeffrey R. Wyatt · 2007 · Defense Technical Information Center (DTIC)
Granulocyte-colony stimulating factor (G-CSF) enhances recovery in mouse model of Parkinson's disease
Shijie Song, Vasyl Sava, Amanda R. Rowe, Kunyu Li, Chuanhai Cao, Takashi Mori, Juan Sanchez‐Ramos · 2010 · Neuroscience Letters
Progressive loss of nigrostriatal dopaminergic neurons induced by inflammatory responses to fipronil
Jae Hyeon Park, Youn Sun Park, Hyun Chul Koh · 2016 · Toxicology Letters
Atorvastatin Prevents Early Oxidative Events and Modulates Inflammatory Mediators in the Striatum Following Intranasal 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Administration in Rats
Naiani Ferreira Marques, Adalberto Alves de Castro, Gianni Mancini, Fernanda Luz Neves da Rocha, Adair R.S. Santos, Rui Daniel Prediger, Andreza Fabro De Bem, Carla I. Tasca · 2017 · Neurotoxicity Research
KMS99220 Exerts Anti-Inflammatory Effects, Activates the Nrf2 Signaling and Interferes with IKK, JNK and p38 MAPK via HO-1.
Ji Ae Lee, Dong Jin Kim, Onyou Hwang · 2019 · PubMed Central
Zocor Forte® (simvastatin) has a neuroprotective effect against LPS striatal dopaminergic terminals injury, whereas against MPP+ does not
Marti Santiago, Ma Carmen Hernández-Romero, Alberto Machado, Josefina Cano · 2009 · European Journal of Pharmacology
A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice
Toshiyuki Kawasaki, Yukio Ago, Tatsuya Kitao, Tetsuaki Nashida, Akiko Takagi, Kazuhiro Takuma, Toshio Matsuda · 2008 · Neuropharmacology
Anti-brain cholinergic auto antibodies from primary Sjögren syndrome sera modify simultaneously cerebral nitric oxide and prostaglandin biosynthesis
Betina E. Orman, Leonor Sterin‐Borda, Alejandra De Couto Pita, Silvia Reina, Enri Borda · 2007 · International Immunopharmacology
Bone Marrow Transplantation Reveals Roles for Brain Macrophage/Microglia TNF Signaling and Nitric Oxide Production in Excitotoxic Neuronal Death
Zhihong Guo, Titilola Iyun, Weiming Fu, Peisu Zhang, Mark P. Mattson · 2004 · NeuroMolecular Medicine
Rapamycin and FK506 derivative TH2849 could ameliorate neurodegenerative diseases through autophagy with low immunosuppressive effect
Li Ding, Wenhao Nan, Xianbing Zhu, Xiaoming Li, Liyan Zhou, Houjie Chen, Lu Yu, Fahim Ullah Khan, Hanbing Zhong, Xiaojun Shi · 2018 · CNS Neuroscience & Therapeutics
Hemin inhibits NO production by IL-1β-stimulated human astrocytes through induction of heme oxygenase-1 and reduction of p38 MAPK activation
Wen S. Sheng, Shuxian Hu, Adam R Nettles, James R. Lokensgard, Gregory M. Vercellotti, Robert Bryan Rock · 2010 · Journal of Neuroinflammation
TFP5/TP5 peptide provides neuroprotection in the MPTP model of Parkinson′s disease
H. Pant, Balachandran Krishnamma Binukumar · 2016 · Neural Regeneration Research
Neuroinflammation as a therapeutic target in neurodegenerative diseases
Richard Gordon, Trent M. Woodruff · 2017 · Elsevier eBooks
The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrain
Sandy Stayte, Kathryn J. Laloli, Peggy Rentsch, Aimee Lowth, Kong M. Li, Russell Pickford, Bryce Vissel · 2019 · Experimental Neurology
Toxin-induced mitochondrial dysfunction
Susan E. Browne, M. Flint Beal · 2002 · International review of neurobiology
A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use as a Therapeutic for Parkinson’s Disease
Shankar J. Chinta, Subramanian Rajagopalan, Abirami Ganesan, Julie Kay Andersen · 2012 · Parkinson s Disease
Quantification of MPTP-induced dopaminergic neurodegeneration in the mouse substantia nigra by laser capture microdissection
Diane T. Stephenson, Andres D. Ramirez, Jill E. Long, Nestor X. Barrezueta, Éva Hajós‐Korcsok, Curt Matherne, Dan Gallagher, Anne Marie Ryan, Ricardo Ochoa, Frank S. Menniti et al. · 2006 · Journal of Neuroscience Methods
Low-dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine causes inflammatory activation of astrocytes in nuclear factor-κB reporter mice prior to loss of dopaminergic neurons
James Adam Miller, Briana R. Trout, Kelly A. Sullivan, Russell Bialecki, Ruth Angela Roberts, Ronald B. Tjalkens · 2011 · Journal of Neuroscience Research
Homocysteine and Parkinson’s Disease: A Complex Relationship
Gayle Helane Doherty · 2013 · Journal of Neurological Disorders
Mouse Models of NO/Natriuretic Peptide/cGMP Kinase Signaling
Franz Bruno Hofmann, Martin Biel, Robert Feil, Thomas Kleppisch · 2004 · Handbook of experimental pharmacology
The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss
Elizabeth M. Kline, Laura M. Butkovich, Joshua M. Bradner, Jianjun Chang, Harris A. Gelbard, Val S. Goodfellow, William Michael Caudle, Malú G. Tansey · 2019 · Experimental Neurology
Protective effect of i Zizyphus spinachristi i on MPP -induced oxidative stress
Thamilarasan Manivasagam · 2018 · Frontiers in Bioscience-Scholar
A novel idea for establishing Parkinson’s disease mouse model by intranasal administration of paraquat
Yibing Chen, Yanqiu Wang, Jia-Rong Wu, Yuan‐Lu Cui · 2020 · Neurological Research
Non-autonomous cell death in Parkinson's disease
Dawson, Ted M · 2008 · The Lancet Neurology
Molecular effects of activated BV-2 microglia by mitochondrial toxin 1-methyl-4-phenylpyridinium
Meihua Jin, Byung Wook Kim, Sushruta Koppula, In Su Kim, Ji-Hwan Park, Hemant Kumar, Dong‐Kug Choi · 2012 · NeuroToxicology
Rôles biologiques des éléments traces dans le cerveau – exemples du Zn et du Fe
Sylvain Bohic, Jean‐François Ghersi‐Egea, J. Gibon, Pierre Paoletti, Josiane Arnaud, Stéphane Hunot, Alain Boom, Alexandre Bouron · 2010 · Revue Neurologique
Autoantibodies from schizophrenia patients induce cerebral cox-1/iNOS mRNA expression with NO/PGE2/MMP-3 production
Sabrina Ganzinelli, Enri Borda, Leonor Sterin‐Borda · 2009 · The International Journal of Neuropsychopharmacology
Enhanced dopaminergic neurotoxicity mediated by MPTP in IL-32β transgenic mice
Yu Yeon Jung, Nikita Katila, Sabita Neupane, Sina Shadfar, Uttam Ojha, Sunil Bhurtel, Sunil Srivastav, Dong Ju Son, Pil‐Hoon Park, Do Young Yoon et al. · 2016 · Neurochemistry International
3-Nitrotyrosine-dependent dopaminergic neurotoxicity following direct nigral administration of a peroxynitrite but not a nitric oxide donor
Mahmoud M. Iravani, Claire O. Haddon, Sarah Rose, Peter G. Jenner · 2006 · Brain Research
Protection against Murine Leukemia Virus-InducedSpongiform Myeloencephalopathy in Mice Overexpressing Bcl-2 butNot in Mice Deficient for Interleukin-6, Inducible NitricOxide Synthetase, ICE, Fas, Fas Ligand, or TNF-R1Genes
Paul Jolicoeur, Chunyan Hu, Tak W. Mak, Jean‐Claude Martinou, Denis George Kay · 2003 · Journal of Virology
Signaling Mechanisms Underlying Toxicant-Induced Gliosis
James Patrick O'Callaghan, Krishnan Sriram · 2004 · CRC Press eBooks
6-Benzyloxyphthalides as selective and reversible monoamine oxidase B inhibitors with antioxidant and anti-neuroinflammatory activities for Parkinson’s disease treatment
Qing Song, Guangjun Yu, Wei Li, Yidan Xu, Shiqin Cong, Xiuxiu Liu, Zhenghuai Tan, Yong Deng · 2022 · Bioorganic Chemistry
Neuroprotective effects of GSK-343 in an in vivo model of MPTP-induced nigrostriatal degeneration
Deborah Mannino, Sarah Adriana Scuderi, Giovanna Casili, Valentina Bova, Laura Cucinotta, Marika Lanza, Alessia Filippone, Emanuela Esposito, Irene Paterniti · 2023 · Journal of Neuroinflammation
Kinetic Study on the Effects of Extremely Low Frequency Electromagnetic Field on Catalase, Cytochrome P450 and Inducible Nitric Oxide Synthase in Human HaCaT and THP-1 Cell Lines
Antonia Patruno, Shams S. M. Tabrez, Paolo Amerio, Mirko Pesce, Giovina Vianale, S. Franceschelli, Alfredo Grilli, Mohammad Amjad Kamal, Marcella Reale · 2011 · CNS & Neurological Disorders - Drug Targets
Inhibition of i-NOS but not n-NOS protects rat primary cell cultures against MPP+-induced neuronal toxicity
Monika J. Brzozowski, Peter G. Jenner, Sarah Rose · 2014 · Journal of Neural Transmission
Rho kinase II interference by small hairpin RNA ameliorates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
Qiong Zhang, Yongfei Zhao, Jianying Xi, Wenbo Yu, Bao‐Guo Xiao · 2016 · Molecular Medicine Reports
Roles of nitric oxide and ethyl pyruvate after peripheral nerve injury
Sandesh Panthi, Kripa Gautam · 2017 · Inflammation and Regeneration
Inhibition of mitochondrial fission and iNOS in the dorsal vagal complex protects from overeating and weight gain
Bianca Patel, Lauryn E. New, Joanne C. Griffiths, Jim Deuchars, B Filippi · 2020 · Molecular Metabolism
Human mAChR antibodies from Sjögren syndrome sera increase cerebral nitric oxide synthase activity and nitric oxide synthase mRNA level
Silvia Reina, Leonor Sterin‐Borda, Betina E. Orman, Enri Borda · 2004 · Clinical Immunology
Pathogenic role of glial cells in Parkinson's disease
Serge Przedborski, James E. Goldman · 2003 · Advances in molecular and cell biology
18β-glycyrrhetinic acid ameliorates MPTP-induced neurotoxicity in mice through activation of microglial anti-inflammatory phenotype
Hanyue Luo, Caishi Zhang, Lujuan He, Zefang Lin, Ji‐chun Zhang, Qi Qi, Jiaxu Chen, Wei Yao · 2023 · Psychopharmacology
Thrombin-Induced Microglia Activation Modulated through Aryl Hydrocarbon Receptors
Meei‐Ling Sheu, Liang-Yi Pan, Cheng-Ning Yang, Jason P. Sheehan, Liang-Yu Pan, Weir-Chiang You, Chien‐Chia Wang, Hung-Chuan Pan · 2023 · International Journal of Molecular Sciences
Neuronal Death Caused by HMGB1-Evoked via Inflammasomes from Thrombin-Activated Microglia Cells
Meei‐Ling Sheu, Liang-Yi Pan, Cheng-Ning Yang, Jason P. Sheehan, Liang-Yu Pan, Weir-Chiang You, Chien‐Chia Wang, Hong-Shiu Chen, Hung-Chuan Pan · 2023 · International Journal of Molecular Sciences
The Brain NO Levels and NOS Activities Ascended in the Early and Middle Stages and Descended in the Terminal Stage in Scrapie-Infected Animal Models
Lina Chen, Jing Fang Sun, Xiaodong Yang, Kang Xiao, Yan Lv, Baoyun Zhang, Wei Min Zhou, Cao Chen, Chen Gao, Qi Shi et al. · 2016 · Molecular Neurobiology
Succinobucol, a Non-Statin Hypocholesterolemic Drug, Prevents Premotor Symptoms and Nigrostriatal Neurodegeneration in an Experimental Model of Parkinson’s Disease
Danúbia Bonfanti Santos, Dirleise Colle, Eduardo Luiz Gasnhar Moreira, Mariana Appel Hort, Marcelo Godoi, Gael Le Douaron, Antonio Luiz Braga, Jamil Assreuy, Patrick Pierre Michel, Rui Daniel Prediger et al. · 2016 · Molecular Neurobiology
Pre-clinical therapeutic development of a series of metalloporphyrins for Parkinson's disease
Liping Liang, Jie Huang, Ruth E. Fulton, Jennifer N. Pearson-Smith, Brian J. Day, Manisha Patel · 2017 · Toxicology and Applied Pharmacology
Differential activation of astrocytes and microglia during post-natal development of dopaminergic neuronal death in the weaver mouse
Aı̈cha Douhou, Thomas Debeir, Patrick Pierre Michel, Léa Stankovski, Lamia Bouslama‐Oueghlani, Catherine Verney, Rita Raisman‐Vozari · 2003 · Developmental Brain Research
Estrogen enhances the number of nigral dopaminergic neurons of adult male mice without affecting nigral neuroglial number and morphology
Wanida Tripanichkul, Em-orn Jaroensuppaperch, David Isaac Finkelstein · 2008 · Neuroscience Letters
Expression of Inducible Nitric Oxide Synthase and Elevation of Tyrosine Nitration of a 32-Kilodalton Cellular Protein in Brain Capillary Endothelial Cells from Rats Infected with a Neuropathogenic Murine Leukemia Virus
Atsushi Jinno‐Oue, Susan G. Wilt, Charlotte A. Hanson, Natalie V. Dugger, Paul M. Hoffman, Michiaki Masuda, Sandra K. Ruscetti · 2003 · Journal of Virology
Do Naturally Occurring Antioxidants Protect Against Neurodegeneration of the Dopaminergic System? A Systematic Revision in Animal Models of Parkinson's Disease
Carmen Costas‐Ferreira, L.R.F. Faro · 2021 · Current Neuropharmacology
TLR2 deficiency is beneficial at the late phase in MPTP-induced Parkinson’ disease mice
Yongtao He, Jiayin Zhao, Hongtian Dong, Xiaoshuang Zhang, Yufei Duan, Yuanyuan Ma, Mei Yu, Jian Fei, Fang Ping Huang · 2023 · Life Sciences
Efficacy and safety of platelet-rich plasma (PRP) in erectile dysfunction (ED): a systematic review and meta-analysis
Haotian Huang, Jiao Qin, Zhi Hong Wen, Yang Liu, Caixia Chen, Chongjian Wang, Hongyuan Li, Xuesong Yang · 2024 · Translational Andrology and Urology
Pramipexole attenuates 6-OHDA-induced Parkinson’s disease by mediating the Nurr1/NF-κB pathway
Hua Gao, Dan Wang, Yuling Wang, Jie-ping Mao, Sen Jiang, Xinling Yang · 2021 · Molecular Biology Reports
CNI-1493 Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in the Acute MPTP Mouse Model of Parkinson's Disease
Carmen Noelker, Vanessa Stuckenholz, Jens‐Peter Reese, Daniel Alvarez‐Fischer, Roman Sankowski, Tanja Katrin Rausch, Wolfgang Hermann Oertel, Andreas Hartmann, Sonya van Patten, Yousef Al‐Abed et al. · 2012 · Neurodegenerative Diseases
Administration of tetrahydrobiopterin restored the decline of dopamine in the striatum induced by an acute action of MPTP
Hiroki Kurosaki, Kentaro Yamaguchi, Kohei Man-yoshi, Shin‐ichi Muramatsu, Satoshi Hara, Hiroshi Ichinose · 2019 · Neurochemistry International
Phenotype, Compartmental Organization and Differential Vulnerability of Nigral Dopaminergic Neurons
Tomás González‐Hernández, Domingo Afonso‐Oramas, Ignacio Cruz‐Muros · 2009 · Springer eBooks
Discovery of novel inhibitors of inducible nitric oxide synthase
Yasuhiro Kita, Masakazu Muramoto, Akihiko Fujikawa, Takao Yamazaki, Yoshitada Notsu, Shintaro Nishimura · 2002 · Journal of Pharmacy and Pharmacology
Nitric oxide alterations in cardiovascular system of rats with Parkinsonism induced by 6-OHDA and submitted to previous exercise
Lorena de Jager, Eric Diego Turossi Amorim, Bruno Fernando Cruz Lucchetti, Fernanda Novi Cortegoso Lopes, Carlos César Crestani, Phileno Pinge‐Filho, Marli Cardoso Martins‐Pinge · 2018 · Life Sciences